Melphalan and Meningitis bacterial - a phase IV clinical study of FDA data

Summary:

Meningitis bacterial is reported as a side effect among people who take Melphalan (melphalan), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Tacrolimus, and have Graft versus host disease.

The phase IV clinical study analyzes which people have Meningitis bacterial when taking Melphalan. It is created by eHealthMe based on reports of 20,050 people who have side effects when taking Melphalan from the FDA, and is updated regularly.

What is Melphalan?

Melphalan has active ingredients of melphalan. eHealthMe is studying from 20,052 Melphalan users. Check the latest studies of Melphalan.

What is Meningitis bacterial?

Meningitis bacterial (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges) is found to be associated with 207 drugs and 383 conditions by eHealthMe. Check the latest studies of Meningitis bacterial.

On Jul, 09, 2026

20,050 people reported to have side effects when taking Melphalan.
Among them, 16 people (0.08%) have Meningitis bacterial.

Could Melphalan cause Meningitis bacterial?

Among these 16 people:

How long have people been on Melphalan when they have Meningitis bacterial? *

What is the gender of people who have Meningitis bacterial when taking Melphalan? *

female: 9.09 %
male: 90.91 %

What is the age of people who have Meningitis bacterial when taking Melphalan? *

What are other drugs people take besides Melphalan? *

What are other side effects people have besides Meningitis bacterial? *

Bacteraemia (presence of bacteria in the blood): 5 people, 31.25%
Enterococcal Infection: 3 people, 18.75%
Enterococcal Bacteraemia (presence of bacteria lactic acid in the blood): 2 people, 12.50%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 12.50%
Alpha Haemolytic Streptococcal Infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans): 1 person, 6.25%
Bacterial Infection: 1 person, 6.25%
Bacterial Sepsis: 1 person, 6.25%
Cellulitis (infection under the skin): 1 person, 6.25%
Device Related Infection: 1 person, 6.25%
Drug Ineffective: 1 person, 6.25%

What are the existing conditions these people have? *

Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 6 people, 37.50%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 31.25%
Multiple Myeloma (cancer of the plasma cells): 3 people, 18.75%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 18.75%
Immunodeficiency Disorders: 3 people, 18.75%
Lymphoma (cancer that begins in immune system cells): 2 people, 12.50%
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Melphalan and have Meningitis bacterial?

- Check whether Meningitis bacterial is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Melphalan:

Melphalan (20,052 reports)

Browse all side effects of Melphalan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Meningitis bacterial:

Meningitis bacterial (207 drugs)

Browse all the conditions that are associated with Meningitis bacterial:

Meningitis bacterial (383 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on melphalan (the active ingredients of Melphalan) and Melphalan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.